About this Event
Imperial Collider returns, providing you the opportunity to meet world-leading researchers across Imperial's health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker is Dr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
Look out for the full speaker lineup and ways to sponsor and partner at the event soon.
What else do I need to know?
- Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
- This is a ticketed event with limited space.
- Venue accessibility information can be viewed via AccessAble.
- Any questions, please contact Dr Prashanthini Jeyarajan: [email protected]
- All guests registering for this event will be expected to adhere to Imperial’s Conference Policy
- Imperial College London – Enterprise Division Privacy Notice
Agenda
🕑: 08:30 AM - 09:20 AM
Registration and morning coffee
🕑: 09:20 AM - 09:30 AM
Opening remarks
Info: Mary Ryan, Vice Provost, Research and Enterprise, Imperial
🕑: 09:30 AM - 10:15 AM
Opening keynote – Accessing innovation to drive the pharma pipeline
Info: Fiona Marshall, President, Biomedical Research, Novartis
🕑: 10:15 AM - 10:45 AM
Building Breakthrough Companies: The Flagship Model of Venture Creation
Info: TBA
🕑: 10:45 AM - 11:15 AM
Flagship Translational Journey: A Rhinovirus Vaccine
Info: Sebastian Johnston, Professor, Respiratory Medicine & Allergy, Imperial
🕑: 11:15 AM - 11:35 AM
Morning break & networking
🕑: 11:35 AM - 12:05 PM
Fleming in practice: tackling grand challenges in antimicrobial resistance
Info: TBA
🕑: 12:05 PM - 01:05 PM
Panel – Biomedical sector landscape and key trends
Info: Fiona Marshall, President, Biomedical Research, Novartis
Ruth McKernan, Executive Chair, Innovate UK
Richard Mason, Chief Executive Officer, Apollo Therapeutics
Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher
Chair: Mike Romanos, Associate Dean for Enterprise, Imperial College London
🕑: 01:05 PM - 02:00 PM
Lunch & networking
🕑: 02:00 PM - 02:45 PM
Keynote – Innovation to enable the pharma industry and precision medicine
Info: Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher
🕑: 02:45 PM - 03:15 PM
Imperial’s clinical advantage: patients, cohorts and translational depth
Info: Graham Cooke, Deputy Dean of the Faculty of Medicine, Imperial. Mark Thursz, Director of AHSC, Professor of Hepatology, Imperial College London
🕑: 02:55 PM - 03:10 PM
Convergence in practice: Digital health, data and the next frontier
Info: Payam Barnaghi, Co-Director, School of Convergence Science (Human and Artificial Intelligence), Imperial College London
🕑: 03:10 PM - 03:55 PM
Panel – Partnering that works: identifying science and building successful col
Info: Kay Penicud, Vice President and Head of Research Partnerships, Apollo Therapeutics
Malcolm Skingle, Former Head of Academic Liaison, GSK
Chair: Prasshy Jeyarajan, Head of Partnerships, Faculty of Medicine, Imperial
🕑: 04:50 PM - 04:55 PM
Closing reflections - Sustaining momentum beyond the Collider
Info: Graham Cooke, Deputy Dean of Faculty of Medicine Imperial College London
🕑: 03:55 PM - 04:50 PM
Translational Science Showcase
Info: Speker to be confirmed
Event Venue & Nearby Stays
The Royal Geographical Society (with IBG), 1 Kensington Gore, London, United Kingdom
GBP 0.00
